BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 12119402)

  • 41. Mechanistic insights into the role of Val75 of HIV-1 reverse transcriptase in misinsertion and mispair extension fidelity of DNA synthesis.
    Matamoros T; Kim B; Menéndez-Arias L
    J Mol Biol; 2008 Feb; 375(5):1234-48. PubMed ID: 18155043
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural alterations in the DNA ahead of the primer terminus during displacement synthesis by reverse transcriptases.
    Winshell J; Champoux JJ
    J Mol Biol; 2001 Mar; 306(5):931-43. PubMed ID: 11237609
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fidelity of nucleic acid amplification with avian myeloblastosis virus reverse transcriptase and T7 RNA polymerase.
    Sooknanan R; Howes M; Read L; Malek LT
    Biotechniques; 1994 Dec; 17(6):1077-80, 1083-5. PubMed ID: 7532977
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of phenylalanine-119 of the reverse transcriptase of mouse mammary tumour virus in DNA synthesis, ribose selection and drug resistance.
    Entin-Meer M; Sevilya Z; Hizi A
    Biochem J; 2002 Oct; 367(Pt 2):381-91. PubMed ID: 12097136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. De novo and DNA primer-mediated initiation of cDNA synthesis by the mauriceville retroplasmid reverse transcriptase involve recognition of a 3' CCA sequence.
    Chen B; Lambowitz AM
    J Mol Biol; 1997 Aug; 271(3):311-32. PubMed ID: 9268661
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The phenylmethylthiazolylthiourea nonnucleoside reverse transcriptase (RT) inhibitor MSK-076 selects for a resistance mutation in the active site of human immunodeficiency virus type 2 RT.
    Auwerx J; Stevens M; Van Rompay AR; Bird LE; Ren J; De Clercq E; Oberg B; Stammers DK; Karlsson A; Balzarini J
    J Virol; 2004 Jul; 78(14):7427-37. PubMed ID: 15220416
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of Moloney murine leukaemia virus/avian myeloblastosis virus chimeric reverse transcriptases.
    Yasukawa K; Mizuno M; Inouye K
    J Biochem; 2009 Mar; 145(3):315-24. PubMed ID: 19060310
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Escherichia coli DNA polymerase III epsilon subunit increases Moloney murine leukemia virus reverse transcriptase fidelity and accuracy of RT-PCR procedures.
    Arezi B; Hogrefe HH
    Anal Biochem; 2007 Jan; 360(1):84-91. PubMed ID: 17107651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Footprint analysis of replicating murine leukemia virus reverse transcriptase.
    Wöhrl BM; Georgiadis MM; Telesnitsky A; Hendrickson WA; Le Grice SF
    Science; 1995 Jan; 267(5194):96-9. PubMed ID: 7528942
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temperature effects on the fidelity of a thermostable HIV-1 reverse transcriptase.
    Álvarez M; Menéndez-Arias L
    FEBS J; 2014 Jan; 281(1):342-51. PubMed ID: 24279450
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis.
    Weiss KK; Chen R; Skasko M; Reynolds HM; Lee K; Bambara RA; Mansky LM; Kim B
    Biochemistry; 2004 Apr; 43(15):4490-500. PubMed ID: 15078095
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The involvement of HIV-1 RNAse H in resistance to nucleoside analogues.
    Roquebert B; Marcelin AG
    J Antimicrob Chemother; 2008 May; 61(5):973-5. PubMed ID: 18325896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of murine leukemia virus reverse transcriptase deoxyribonucleoside triphosphate-binding site in retroviral replication and in vivo fidelity.
    Halvas EK; Svarovskaia ES; Pathak VK
    J Virol; 2000 Nov; 74(22):10349-58. PubMed ID: 11044079
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.
    Xu W; Morrow CD
    Virology; 2006 Sep; 352(2):380-9. PubMed ID: 16781756
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chimeric thermostable DNA polymerases with reverse transcriptase and attenuated 3'-5' exonuclease activity.
    Schönbrunner NJ; Fiss EH; Budker O; Stoffel S; Sigua CL; Gelfand DH; Myers TW
    Biochemistry; 2006 Oct; 45(42):12786-95. PubMed ID: 17042497
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A single amino acid in the reverse transcriptase domain of hepatitis B virus affects virus replication efficiency.
    Lin X; Yuan ZH; Wu L; Ding JP; Wen YM
    J Virol; 2001 Dec; 75(23):11827-33. PubMed ID: 11689664
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Murine leukemia virus with a primer-binding site complementary to tRNALys,3 adapts to select new tRNAs for replication following extended in vitro culture.
    Palmer MT; McPherson S; Morrow CD
    Virology; 2005 Mar; 333(2):337-48. PubMed ID: 15721366
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Lysine directed cross-linking of viral DNA-RNA:DNA hybrid substrate to the isolated RNase H domain of HIV-1 reverse transcriptase.
    Guaitiao JP; Zúñiga RA; Roth MJ; Leon O
    Biochemistry; 2004 Feb; 43(5):1302-8. PubMed ID: 14756566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Detection of reverse transcriptase activity in human melanoma cell lines and identification of a murine leukemia virus contaminant.
    Deichmann M; Huder JB; Kleist C; Näher H; Schüpbach J; Böni J
    Arch Dermatol Res; 2005 Feb; 296(8):345-52. PubMed ID: 15630577
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Substrate variations that affect the nucleic acid clamp activity of reverse transcriptases.
    Oz-Gleenberg I; Herzig E; Voronin N; Hizi A
    FEBS J; 2012 May; 279(10):1894-903. PubMed ID: 22443410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.